1. Generic & Brand Names
Generic: Cefixime
Brands: Suprax® (Global), Fixit® (India), Cefspan® (Japan)
Formulations:
Tablets (200mg, 400mg)
Oral suspension (100mg/5mL after reconstitution)
No IV/IM formulations
2. Drug Class & Mechanism
Class: 3rd-generation oral cephalosporin
Mechanism: Inhibits bacterial cell wall synthesis → bactericidal
Spectrum:
Gram-negative: H. influenzae, M. catarrhalis, E. coli, P. mirabilis, N. gonorrhoeae
Gram-positive: S. pneumoniae (penicillin-susceptible only), S. pyogenes
NOT for: MRSA, Pseudomonas, Enterococci
3. FDA-Approved Uses
| Infection Type | Key Pathogens | First-Line? |
|---|---|---|
| Otitis Media (AOM) | H. influenzae, M. catarrhalis | Alternative |
| Pharyngitis/Tonsillitis | S. pyogenes (Group A Strep) | Penicillin-allergic patients |
| Uncomplicated UTI | E. coli, P. mirabilis | Last-line (resistance concerns) |
| Acute Bronchitis | H. influenzae, M. catarrhalis | Avoid (usually viral) |
| Gonorrhea | N. gonorrhoeae (uncomplicated) | Dual therapy only |
4. Dosing Regimens
| Infection Type | Adult Dose | Pediatric Dose (≥6 mo) |
|---|---|---|
| AOM/Pharyngitis | 400 mg daily | 8 mg/kg/day in 1-2 doses |
| Uncomplicated UTI | 400 mg daily x 7 days | Not recommended <12 years |
| Gonorrhea | 400 mg single dose + Azithromycin 1g | N/A |
| Renal Adjustment: |
CrCl 20-59 mL/min: ↓ dose by 25%
CrCl <20 mL/min: ↓ dose by 50%
5. Resistance Concerns
| Pathogen | Resistance Rate (US) | Clinical Implication |
|---|---|---|
| S. pneumoniae | 25-40% | Avoid for pneumonia |
| E. coli (UTI) | 20-35% | Use only if susceptible |
| H. influenzae | 10-15% (β-lactamase+) | Combine with clavulanate? |
| N. gonorrhoeae | 5-10% | Always dual therapy |
6. Side Effects
| Common (≥10%) | Serious (<1%) |
|---|---|
| Diarrhea | Anaphylaxis (cross-reacts with penicillin) |
| Loose stools | C. difficile colitis |
| Nausea | Stevens-Johnson Syndrome |
| Vaginal candidiasis | Hepatotoxicity |
| Headache | Interstitial Nephritis |
7. Black Box Warnings & Contraindications
🚫 Absolute Contraindications:
Anaphylaxis to penicillins/cephalosporins (10% cross-reactivity)
Severe renal impairment without dose adjustment
High-Risk Groups:
Penicillin-allergic: Test skin if IgE-mediated history
Elderly: ↑ C. difficile risk (avoid if recent antibiotics)
Pregnancy (Category B): Use only if benefit > risk
8. Drug Interactions
| Medication | Effect | Management |
|---|---|---|
| Carbamazepine | ↑ Levels → toxicity | Monitor serum levels |
| Warfarin | ↑ INR → bleeding | Monitor INR |
| Probenecid | ↑ Cefixime levels | Avoid combo |
9. Clinical Use Cases
| Scenario | Recommendation |
|---|---|
| Strep throat in penicillin-allergic patient | 400 mg daily x 10 days |
| Uncomplicated UTI with susceptible E. coli | 400 mg daily x 7 days |
| AOM after amoxicillin failure | 8 mg/kg/day x 10 days |
| Gonorrhea | Single 400 mg dose + Azithromycin 1g |
10. Storage & Administration
Suspension:
Reconstitute with water → yields 100mg/5mL
Refrigerate (discard after 14 days)
Tablets:
Store at 15-30°C (59-86°F)
Take with/without food (food delays absorption)
Key Limitations & Alternatives
Why It's Falling Out of Favor
UTIs: Rising E. coli resistance (>30% in some regions)
Respiratory: Ineffective against penicillin-resistant pneumococci
Gonorrhea: CDC recommends ceftriaxone IM as first-line (higher efficacy)
Stewardship Tip: Reserve for culture-confirmed susceptible infections when first-line agents contraindicated.
Patient Counseling Points
"Complete full course – even if symptoms improve."
Diarrhea warning: "Stop drug if watery/bloody stools appear."
Allergy alert: "Seek ER for hives/swelling/difficulty breathing."
Suspension: "Shake well; use measuring device (not spoon)."
💡 Pro Tip: For penicillin-allergic patients with anaphylaxis history, avoid all β-lactams – use macrolides (azithromycin) instead.
Comments
Post a Comment